- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
University of Utah
Headquarters: Salt Lake City, UT, United States
Website: http://www.utah.edu
Year Founded: 1850
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Sep 4, 2024
Product Development
Clinical Report: Alnylam’s HELIOS-B details trigger market reaction
Plus: Vaxcyte pneumococcal vaccine win, and data from Recursion, Arrowhead and Praxis
BioCentury | Apr 15, 2023
Discovery & Translation
Optimized Cas9 nickases for prime editing, Amunix’s masked T cell engagers and more
BioCentury’s roundup of translational news
BioCentury | Feb 16, 2023
Emerging Company Profile
Aera: delivering nucleic acids with endogenous human proteins
Feng Zhang’s latest company aims to solve the genetic medicine delivery problem
BioCentury | Feb 9, 2022
Discovery & Translation
Translational trendspotting: a Distillery dive into infectious disease
Host targets, cross-reactive mAbs and COVID-19 countermeasures stand out in BioCentury’s Distillery
BioCentury | Oct 27, 2021
Distillery Therapeutics
CHMP3 retrocopies for HIV, Ebola and other infections
BioCentury | Aug 24, 2021
Emerging Company Profile
Atavistik: Identifying allosteric modulators of metabolic proteins
Emerging Company Profile: Utah spinout launching with $60M to identify
BioCentury | Aug 21, 2021
Translation in Brief
Feng Zhang’s SEND mRNA delivery platform; plus in vivo CRISPR screening with MIC-Drop and more
BioCentury’s roundup of translational news
BioCentury | Jul 2, 2021
Distillery Therapeutics
Natural lipopeptide antibiotics for Acinetobacter infections
DISEASE CATEGORY: Infectious disease
INDICATION: Gram-negative bacterial infection University of Utah researchers identified two lipopeptide antibiotics derived from a marine shipworm symbiont that
INDICATION: Gram-negative bacterial infection University of Utah researchers identified two lipopeptide antibiotics derived from a marine shipworm symbiont that
BioCentury | Nov 21, 2020
Politics, Policy & Law
Fate of Trump’s 11th hour drug price rules uncertain
Legal and logistic challenges could block implementation of most favored nation, rebate rules
Items per page:
1 - 10 of 203